Lantheus Holdings (LNTH) Interest Expenses (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Interest Expenses came in at $49.0 million in Q1 2026, up 107.0% year-on-year from $23.7 million in Q1 2025, and up 865.75% on a QoQ basis from $5.1 million in Q4 2025.
Lantheus Holdings (LNTH) Interest Expenses (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Interest Expenses data on file, last reported at $49.0 million in Q1 2026.
- On a quarterly basis, Interest Expenses rose 107.0% year-over-year to $49.0 million in Q1 2026; TTM through Mar 2026 was $49.0 million, a 107.0% increase from a year earlier, with the FY2025 full-year figure at $180.5 million, down 99.49% from the prior year.
- Interest Expenses for Q1 2026 stood at $49.0 million, up from $5.1 million in the prior quarter.
- Over the last five years, Interest Expenses for LNTH reached as high as $57.9 million in Q3 2025 and fell as low as $460000.0 in Q4 2022.
- Historically, Interest Expenses has averaged $22.5 million across 5 years, with a median of $23.6 million in 2025.
- Across the five-year window, Interest Expenses tumbled 75.09% in 2024 and jumped 1081.52% in 2025, its largest moves.
- Year by year, Interest Expenses stood at $460000.0 in 2022, then soared by 995.87% to $5.0 million in 2023, then advanced by 0.08% to $5.0 million in 2024, then gained by 0.65% to $5.1 million in 2025, then soared by 865.75% to $49.0 million in 2026.
- Per Business Quant data, the three most recent Interest Expenses figures were $49.0 million in Q1 2026, $5.1 million in Q4 2025, and $57.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.77 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 49.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.04 Mn |
| Mar 31, 2026 | 49.04 Mn |
| Dec 31, 2025 | 5.08 Mn |
| Dec 31, 2025 | 5.08 Mn |
| Sep 30, 2025 | 57.93 Mn |
| Sep 30, 2025 | 57.93 Mn |
| Jun 30, 2025 | 23.65 Mn |
| Jun 30, 2025 | 23.65 Mn |
| Mar 31, 2025 | 23.69 Mn |
| Mar 31, 2025 | 23.69 Mn |
| Dec 31, 2024 | 5.05 Mn |
| Dec 31, 2024 | 5.05 Mn |
| Sep 30, 2024 | 4.90 Mn |
| Sep 30, 2024 | 4.90 Mn |
| Jun 30, 2024 | 21.95 Mn |
| Jun 30, 2024 | 21.95 Mn |
| Mar 31, 2024 | 16.20 Mn |
| Mar 31, 2024 | 16.20 Mn |
| Dec 31, 2023 | 5.04 Mn |
| Dec 31, 2023 | 5.04 Mn |